News – Page 992 – Endpoints News

Sanofi Genzyme has its expansive sights set on a new tech campus in Cambridge — report

7 years ago

SQZ play: Roche doubles down on a $1.37B-plus deal for a new approach to immuno-oncology out of Bob Langer's lab

7 years ago

Following the exodus at Immunocore, Eliot Forster takes the reins at F-star — how long before the crossover and an ...

7 years ago

Experts offer a solid endorsement for AcelRx pain med, spurring a big rally for their stock

7 years ago

#BIIS18 Interview: OrbiMed Asia's Jonathan Wang on his upbringing, deciding against a consulting career, blunt advice ...

7 years ago

Allogene IPO shares rally in the midst of a market storm; The flip side? Hoth files for $13M IPO

7 years ago

Seeking cash to fund PhIII for once-failed drug, Adynxx rides Alliqua's shell to Nasdaq

7 years ago

Merck KGaA posts mixed data from their big PhIIb MS study on evobrutinib — spurring plenty of questions

7 years ago

Perrigo taps ex-tobacco exec as new CEO; Dana Farber T cell investigator Nick Haining joins Merck

7 years ago

Bristol-Myers concedes a PhIII lung cancer flop for Opdivo as competition heats up in SCLC

7 years ago

FDA sets record for number of generic drug approvals again

7 years ago

AbbVie staves off another US Humira knockoff to 2023 as European launch looms

7 years ago

Hit by FDA red flags, cited for misleading investors and battered by a thumbs-down from experts, it’s been one ...

7 years ago

Immune Design buries its PhIII work on cancer, and investors hit the panic button

7 years ago

Otsuka invests $88M into digital meds deal with Proteus; Celgene amps up research pact with Evotec

7 years ago

AcelRx rally quickly fizzles after FDA offers a guarded warning about its latest pain drug pitch

7 years ago

Trump signs bills to eliminate pharmacy ‘gag’ clauses

7 years ago

Teva-partnered Celltrion biosimilar scores FDA adcomm recommendation for a second shot at shaking up Roche's Rituxan ...

7 years ago

Bristol-Myers embraces a possible checkpoint collaborator, snagging a batch of stock and lining up a potential deal

7 years ago

CRISPR Therapeutics, Vertex set for first sickle cell disease trial after FDA lifts clinical hold — just don't look ...

7 years ago

Arie Belldegrun and David Chang score record IPO, now they plan to win the race to a historic FDA OK

7 years ago

Ex-Celgene dealmaker George Golumbeski joins up to guide Carrick on its cancer drug quest — and maybe an IPO as ...

7 years ago

LogicBio guns for $75M IPO; Alexandria lands a new biotech building on Long Island

7 years ago

Roche puts down $75M to sign on as new partner for Ionis' dry AMD drug, following Huntington's deal

7 years ago

First page Previous page 989 990 991992993 994 995 Next page Last page